Intratumoral immunotherapy of established solid tumors with chitosan/IL-12. - Wikidata - awgldk - TriplyDB

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

http://www.wikidata.org/entity/Q36310762

about

Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy.In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer.Polymeric nanoparticles: potent vectors for vaccine delivery targeting cancer and infectious diseases.Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development.Clostridium sporogenes delivers interleukin-12 to hypoxic tumours, producing antitumour activity without significant toxicity.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.

P2860

Q28084489-A35342E5-261C-4F02-A682-02DEDE6AE399 Q33612179-B3914CFF-505B-420F-993F-05B67B949C7A Q34356322-CF556F0F-6F7C-4F35-A4D6-62E580E7272F Q35157433-6B0B9AB0-4ECA-40E2-96FE-E516C6F07422 Q36553255-88D44B90-25A9-416B-A2E5-2320946E61B9 Q36702887-D377E1B0-3199-45F3-8FE4-B98465C9F596 Q36731317-354649E9-6093-469C-815A-48F385B76588 Q37616492-86CA96C3-333B-4B18-94F3-4B5FE9C940DD Q38152851-6936E514-85A3-46BA-88DC-278D2FE66F9E Q41298215-445E892C-25F3-4985-8694-1D72FC620B17 Q42317402-32151638-4F62-4B63-8311-7208F8847B5E Q51701384-AAE08C83-2F1E-4EEA-8F8E-9F8175D05AD8 Q55162750-58B8658F-72BC-4218-A8A1-08925D166D8D

P2860

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

http://www.wikidata.org/entity/Q36310762

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@ast

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@en

type

label

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@ast

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@en

prefLabel

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@ast

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@en

P1433

Q36310762-3C88DFC0-4D00-4F22-8115-46E646CD2C67

P1476

Q36310762-5D750FFB-FE26-4F30-B483-9AD161C87F05

P2093

Q36310762-5D4B69C1-A395-47D4-A240-DC0DCA931AAA

Q36310762-8001363F-04C0-4DEB-B8E3-4F507CBF17EB

Q36310762-E92E68A7-DFAC-44CE-8819-268083836E5F

Q36310762-ED2B3ACB-B281-4153-BDB9-B00CEF63C737

P2860

Q36310762-00D05E3F-179C-4E5F-A246-AE37539F0B7D

Q36310762-04B79BB8-3B81-410A-A36F-47B8D254DA3D

Q36310762-0E7F830D-2FCF-4392-8E2A-161E57D63F40

Q36310762-2A5EDDD8-B2A6-4829-A559-A2FFA9D2C57A

Q36310762-352D7017-536E-47B0-9995-A248B6617C01

Q36310762-450D1EAF-268F-458E-B8DE-9175DC4C6EEC

Q36310762-480D22DE-A38B-46A1-9DA9-64BE129251BA

Q36310762-484A47CC-85A4-4FBC-811F-6CA0F4C03056

Q36310762-5C8A655E-AFB8-442F-9ABD-7E2CC52AF5E0

Q36310762-616F48BA-6A34-4832-9BAD-44C41602BCFF

P304

Q36310762-D9DFBC36-1324-453E-94DD-80FD2C482C56

P31

Q36310762-D18DDAE2-CD9F-4108-811D-F533BBDA8213

P356

Q36310762-A0CB455C-D7D8-4B12-99A4-544C60446869

P433

Q36310762-6E40D609-FEBA-4E74-932E-A2BC9008085E

P478

Q36310762-5D12619F-079D-4B36-90FF-1ABC66613126

P50

Q36310762-DF3CB791-EF61-439E-919F-89655435FBF4

P577

Q36310762-63022F03-07BA-4F5A-8C77-DC65A215D0EF

P5875

Q36310762-2361C028-9C28-4449-97E2-769A62F1ED9B

P698

Q36310762-92D6A173-1882-4682-9D15-153CD1829220

P921

Q36310762-0EFAD08D-760E-4876-9FB7-27282D099D53

P932

Q36310762-F1D79259-5A31-463A-9F27-707C21EE9E99

P356

CJI.0B013E3181EB826D

P1433

Journal of Immunotherapy

P1476

Intratumoral immunotherapy of established solid tumors with chitosan/IL-12.

@en

P2093

Connie J Rogers

http://www.w3.org/2001/XMLSchema#string

Jeffrey Schlom

http://www.w3.org/2001/XMLSchema#string

John W Greiner

http://www.w3.org/2001/XMLSchema#string

Kenneth W Hance

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Chitosan: some pharmaceutical and biological aspects--an update.

Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

Effect of chitosan on weight loss in overweight and obese individuals: a systematic review of randomized controlled trials.

Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids.

Gene therapy of cancer based on interleukin 12.

Review: novel nonviral delivery approaches for interleukin-12 protein and gene systems: curbing toxicity and enhancing adjuvant activity.

Chitosan solution enhances the immunoadjuvant properties of GM-CSF.

Targeted delivery of murine IFN-gamma using a recombinant fowlpox virus: NK cell recruitment to regional lymph nodes and priming of tumor-specific host immunity.

Interleukin-12: biological properties and clinical application.

P304

697-705

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CJI.0B013E3181EB826D

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45389313

http://www.w3.org/2001/XMLSchema#string

P698

20664357

http://www.w3.org/2001/XMLSchema#string

P921

P932

3468951

http://www.w3.org/2001/XMLSchema#string